SUMMARY One thousand and eighty non-pregnant women aged 16-34 years, presenting for the first time at a clinic for sexually transmitted diseases (STD), were examined and screened for infection with Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Candida species. The respective prevalence rates were 21 107o, 20 7Gb, 13-4%o, and 27-807o. Isolation rates for C trachomatis, either occurring alone or in association with other genital infections, were significantly greater in women using oral contraceptive agents. This was not because oral contraceptive users were more promiscuous.
Introduction
Patients and methods After a full history had been taken, patients were examined in the lithotomy position. Specimens for immediate microscopy and the appropriate culture were taken from the urethra and cervix for the identification of N gonorrhoeae and from the posterior forniceal pool for T vaginalis and Candida species. The methods of specimen collection, cultural techniques, and diagnostic criteria have been described. II Specimens for culture for C trachomatis were collected by rotating a cottonwool swab in the cervical canal and on any exposed ectopic columnar epithelium. The swabs were then placed in transport medium (McCoy cell growth medium with 0-5o glucose and 10%o sorbitol) and stored at 4°C before being transferred to the virology laboratory. The method used for isolating C trachomatis in untreated McCoy cells has been described. ' 
Results

ISOLATION RATES
The isolation rates for C trachomatis, N gonorrhoeae, T vaginalis, and Candida species in the 1080 women studied are given in table I. C trachomatis was found in 160 (26 6%) of all 601 oral contraceptive users compared with only 72 (15%) of all 479 non-users (P<0 001). T vaginalis was found significantly less frequently in oral contraceptive users (11%) than in non-users (16-5%) (P<0-02). There were no significant differences between oral contraceptive users and non-users in the incidences of N gonorrhoeae, Candida species, or of women uninfected with any of these four pathogens. 
Concomitant infections
The incidences of concomitant infection with C trachomatis in all women infected with N gonorrhoeae, T vaginalis, and Candida species were 37-5%, 29*0%, and 16-0% respectively (table III) .
In each of these groups, the incidence of concomitant infection with C trachomatis was significantly increased in oral contraceptive users compared with non-users. Thus, whether occurring as the sole pathogen or in association with another genital pathogen, infection with C trachomatis was significantly more common in oral contraceptive users than in non-users. women 60 (66-7%) were asymptomatic; there were no differences in the presence and type of symptoms between oral contraceptive users and non-users. However, oral contraceptive users infected with C trachomatis alone had cervicitis significantly more often than non-users (P<0-01).
Discussion
The isolation of C trachomatis from 21%o of women aged between 16 and 34 years attending the Leeds clinic is comparable with the isolation rates found in a smaller previous study'0 in the same department and in recent studies elsewhere in England. We also noted that a small percentage of women in whom no pathogen other than C trachomatis could be isolated also had a vulvovaginitis with a frothy mucopurulent vaginal discharge with or without cervical abnormalities. The finding of a reduced incidence of trichomoniasis in oral contraceptive users in this study, in which the diagnosis was made by both microscopy and culture, confirms an earlier report, in which the diagnosis was made by microscopy alone. 16 The present study suggests a clear association between C trachomatis infection, whether occurring alone or with concomitant gonorrhoea, trichomoniasis, or candidosis, and the use of oral contraceptive agents. It confirms previous studies of both selected3 and non-selected2 groups of women attending STD clinics and a gynaecological clinic,4 which showed a similar increased incidence of chlamydial infection in oral contraceptive users. We found no evidence that this effect was related to increased promiscuity in such women. Indeed non-users of oral contraceptives with chlamydial infection had multiple sexual partners significantly more often. It is still not clear, however, whether the increased isolation rate is due to a greater infectivity in oral contraceptive users-perhaps because of increased exposed susceptible columnar epithelium-or to easier detection of C trachomatis by present cultural methods, possibly as a result of a stimulative effect of steroids on the growth of C trachomatis'7 within the cervical epithelium.
This study clearly emphasises the importance of a routine chlamydial culture service in women attending STD clinics, particularly as the number of young women using oral contraceptive agents is increasing and may well serve to increase the potential reservoir for chlamydial infection within the community. 
